Lucid Psycheceuticals Announces Exclusive License to Develop Cutting-Edge Neurodegenerative Disease Therapeutics
June 14, 2021 08:15 ET
|
Lucid Psycheceuticals Inc.
TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Lucid Psycheceuticals Inc. (Lucid), a psychedelics-inspired company focusing on total brain health, today announced that it has entered into a world-wide...